1.Construction and verification of the prediction model of pulmonary infection in patients with aneurysmal subarachnoid hemorrhage after craniotomy
Shufang SHI ; Yanjun ZHANG ; Mingxia GUO ; Jingwen CHEN ; Kexing JI ; Xiaolong CHEN ; Jing ZHAO ; Xinmin DING
Chinese Journal of Practical Nursing 2025;41(34):2685-2693
Objective:To construct and verify a risk prediction model for pulmonary infection in patients with aneurysmal subarachnoid hemorrhage (aSAH) after craniotomy and clipping, providing theoretical basis and practical guidance for improving the quality of postoperative care.Methods:Using the convenience sampling method, a retrospective selection was made of 397 patients with aSAH after craniotomy and clipping who were hospitalized in the Department of Neurosurgery of Shanxi Bethune Hospital (Shanxi Academy of Medical Sciences) from January 2019 to December 2023 as the modeling group. They were randomly divided into the training set and the test set at a ratio of 7:3, with 278 cases in the training set and 119 cases in the test set. Patients were divided into the infection group and the non-infection group based on whether they developed pulmonary infection. Univariate analysis was used to model the risk factors of pulmonary infection after aSAH craniotomy and clamping in the group, and Lasso regression was used to construct a predictive model. A total of 119 patients with aSAH admitted to the neurosurgery department of the same hospital from January to April 2024 were selected for the external validation of the model. The predictive effect of the model was evaluated through the receiver operating characteristic (ROC) curve.Results:In the modeling group, there were 216 male patients and 181 female patients. The incidence of pulmonary infection was 38.54% (153/397). Finally, five influencing factors, namely stroke, Hunt-Hess classification, mechanical ventilation, indwelling nasogastric tube and the timing of initiating enteral nutrition, were included to construct a predictive model. The areas under the ROC curves of the nomogram prediction models of this model in the training set, test set, and external validation group were 0.859(95% CI 0.791-0.928), 0.843(95% CI 0.796-0.890), and 0.800(95% CI 0.711-0.889), respectively. The calibration curve shows that the model's prediction fits well with the actual situation and has a high degree of calibration. Decision curve analysis indicates that this model has high clinical application value under different risk thresholds. Conclusions:The risk prediction model for pulmonary infection in patients after craniotomy and clipping with aSAH has good discrimination and calibration, which can provide reference for medical staff to identify high-risk patients at an early stage and take preventive intervention measures.
2.The current situation and prospect for the diagnosis and treatment of metanephric adenoma
Wujie CHEN ; Jun GU ; Enxiu LUO ; Mengdi ZHOU ; Yinglong HUANG ; Haohao LI ; Haidan LI ; Zhiyong TAN ; Haifeng WANG ; Mingxia DING
Chinese Journal of Urology 2025;46(6):472-475
Metanephric adenoma is a rare renal epithelial tumor with a low incidence and lack of specific clinical manifestations,resulting in a lack of uniformity in clinical understanding and treatment. Its etiology and pathogenesis are still unclear,and it may be related to the abnormal number and structure of chromosomes 2,7,and 17,as well as mutations in genes such as BRAF V600E,NF1,and NOTCH1,etc. There may be a transformed relationship between this tumor and Wilms’ tumor and papillary renal cell carcinoma. For diagnosis,it has diverse but non-specific clinical manifestations,and it is difficult to accurately differentiate it from other tumors in the imaging examination,and the confirmation of diagnosis relies on pathological and immunohistochemical staining. Treatment is mainly based on surgery to preserve the renal unit,such as partial nephrectomy,etc.,but the difficulty of preoperative diagnosis often leads to over-treatment,and there is a lack of standardized treatment protocols for metastatic posterior renal adenoma. The aim of this article is to provide a reference for the in-depth understanding of posterior renal adenomas and to optimize the clinical diagnosis and treatment strategies.
3.Practice and reflection on promoting development through interdisciplinary integration in an affiliated hospital of a university
Lihui YU ; Zhong CHEN ; Lu DING ; Fang WANG ; Mingxia YU ; Zhongqiang YUE
Chinese Journal of Medical Science Research Management 2025;38(3):203-213
Objective:To summarize the theoretical basis and practical experience of the hospital where the author works, in actively promoting the interdisciplinary integration of ″Medicine+ ″, and provide reference for hospitals of the same type.Methods:Based on the Resource-Based View framework, this study analyzed the core dimension heterogeneous resources including organizational capital, physical and financial capital, and human capital through a case study of Zhongnan Hospital of Wuhan University, systematically examining its interdisciplinary research promotion strategies.Results:The hospital had created a strong interdisciplinary atmosphere. Its scientific research and innovation capabilities had been significantly enhanced. High-quality interdisciplinary academic achievements had emerged continuously. And its academic influence has continued to expand.Conclusions:Interdisciplinary integration is a systematic project that requires organized implementation and a ″multi-pronged approach″: coordinating and innovating the organizational management system, conducting comprehensive resource inventorying and ensuring sustainable provision, making overall plans for talent introduction and cultivation, and adhering to the clinical-problem-oriented approach in carrying out interdisciplinary integration.
4.Effects and its mechanism of Jingui shenqi pill on diabetic nephropathy-related osteoporosis in rats
Wenjun DING ; Mingxia SHEN ; Yongrui GAO
China Pharmacy 2025;36(16):2000-2004
OBJECTIVE To explore the effect of Jinkui shenqi pill and its potential mechanism on diabetic nephropathy-related osteoporosis (DNOP) in rats. METHODS The rats were randomly divided into blank control group, control group, model group, Jingui shenqi pill low-, medium- and high-dose groups (0.62, 1.24, 2.48 g/kg), and positive control group (denosumab 3 mg/ kg), with 12 cases in each group. Except for the blank control group and the control group, models of DNOP were constructed in the remaining groups by high-glucose and high-fat forage, 3% fructose solution for feeding+intraperitoneal injection of streptozotocin solution. At 2 d after successful molding, Jingui shenqi pill low-, medium- and high-dose groups, and positive control group were given intragastric administration or subcutaneous injection of the corresponding drugs, once a day, for consecutive 8 weeks. After the last administration, bone mineral density (BMD) and serum bone metabolism-related indexes [osteocalcin (OC), calcium, phosphorus, alkaline phosphatase (ALP), tartrate-resistant acid phosphatase (TRAP)] were detected. The pathological changes of right femoral tissues were observed, and the expressions of receptor activator of NF-κB ligand (RANKL)/receptor activator of NF-κB (RANK)/osteoprotegerin (OPG) pathway-related mRNAs and proteins in left femoral tissues were detected. RESULTS Compared with the blank control group and the control group, there was rupture of bone trabecula and severe structural damage in the model group, and tissue space was obvious. BMD and ALP activities, mRNA and protein expressions of OPG were significantly decreased or down-regulated, while the levels of OC, calcium and phosphorus, TRAP activity, mRNA and protein expressions of RANKL and RANK were significantly increased or up-regulated (P<0.05). Compared with the model group, the number of bone trabeculae was increased in all Jingui shenqi pill groups, and the arrangement of bone trabeculae was more regular and dense. The above indexes generally were improved in a certain dose-dependent manner (P<0.05). CONCLUSIONS Jingui shenqi pill can promote osteogenesis and regulate the balance of bone metabolism in DNOP rats, which may be related to down-regulating the expressions of RANKL and RANK, and up-regulating the expression of OPG.
5.The current situation and prospect for the diagnosis and treatment of metanephric adenoma
Wujie CHEN ; Jun GU ; Enxiu LUO ; Mengdi ZHOU ; Yinglong HUANG ; Haohao LI ; Haidan LI ; Zhiyong TAN ; Haifeng WANG ; Mingxia DING
Chinese Journal of Urology 2025;46(6):472-475
Metanephric adenoma is a rare renal epithelial tumor with a low incidence and lack of specific clinical manifestations,resulting in a lack of uniformity in clinical understanding and treatment. Its etiology and pathogenesis are still unclear,and it may be related to the abnormal number and structure of chromosomes 2,7,and 17,as well as mutations in genes such as BRAF V600E,NF1,and NOTCH1,etc. There may be a transformed relationship between this tumor and Wilms’ tumor and papillary renal cell carcinoma. For diagnosis,it has diverse but non-specific clinical manifestations,and it is difficult to accurately differentiate it from other tumors in the imaging examination,and the confirmation of diagnosis relies on pathological and immunohistochemical staining. Treatment is mainly based on surgery to preserve the renal unit,such as partial nephrectomy,etc.,but the difficulty of preoperative diagnosis often leads to over-treatment,and there is a lack of standardized treatment protocols for metastatic posterior renal adenoma. The aim of this article is to provide a reference for the in-depth understanding of posterior renal adenomas and to optimize the clinical diagnosis and treatment strategies.
6.Practice and reflection on promoting development through interdisciplinary integration in an affiliated hospital of a university
Lihui YU ; Zhong CHEN ; Lu DING ; Fang WANG ; Mingxia YU ; Zhongqiang YUE
Chinese Journal of Medical Science Research Management 2025;38(3):203-213
Objective:To summarize the theoretical basis and practical experience of the hospital where the author works, in actively promoting the interdisciplinary integration of ″Medicine+ ″, and provide reference for hospitals of the same type.Methods:Based on the Resource-Based View framework, this study analyzed the core dimension heterogeneous resources including organizational capital, physical and financial capital, and human capital through a case study of Zhongnan Hospital of Wuhan University, systematically examining its interdisciplinary research promotion strategies.Results:The hospital had created a strong interdisciplinary atmosphere. Its scientific research and innovation capabilities had been significantly enhanced. High-quality interdisciplinary academic achievements had emerged continuously. And its academic influence has continued to expand.Conclusions:Interdisciplinary integration is a systematic project that requires organized implementation and a ″multi-pronged approach″: coordinating and innovating the organizational management system, conducting comprehensive resource inventorying and ensuring sustainable provision, making overall plans for talent introduction and cultivation, and adhering to the clinical-problem-oriented approach in carrying out interdisciplinary integration.
7.Exploration of the Pharmacological Substances Basis and Potential Mechanism of Anchang Formulation in the Treatment of Ulcerative Colitis Based on UPLC-Q-TOF-MS Technology and Network Pharmacology
Mingxia WU ; Nan WANG ; Yelin DING ; Mengsitong LI ; Yunqi CUI ; Zhenzhong WANG ; Yingbo YANG ; Wei XIAO
Journal of Nanjing University of Traditional Chinese Medicine 2025;41(5):622-636
OBJECTIVE To identify and characterize the chemical ingredients of Anchang formulation,further screen the active ingredients of this formulation treating ulcerative colitis by network pharmacology,and explore the potential targets and pathways,provi-ding scientific basis for its mechanism research and clinical application.METHODS Chemical ingredients in Anchang formulation were acquired by Ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry(UPLC-Q-TOF-MS)technology and literature retrieval.The potential active ingredients and key targets for the treatment were obtained from Swiss Target Prediction,GeneCards,STRING,and then Gene Ontology(GO)function and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment were analyzed in the DAVID database.The interactions between the active ingredients and the core targets were verified by using the AutoDock software.The RAW 264.7 murine-derived macrophage inflammation model was also established to val-idate the anti-inflammatory activity of the pre-screened chemical ingredients and further explore the related mechanisms.RESULTS In this study,108 chemical ingredients of Anchang formulation were characterized by UPLC-Q-TOF-MS technology,and expanded to 134 through literature search.The component-target network where 39 core active components were screened was further constructed,and 15 key therapeutic targets were screened by the protein-protein interaction network constructed.The enrichment analysis of KEGG pathway indicated that Anchang formulation can regulate TNF,PI3K-Akt,MAPK,cancer and other related signaling pathways and ex-ert a therapeutic effect.The results of cell experiments showed that Anchang formulation and its active ingredients could inhibit the re-lease of NO,TNF-α and IL-6 in the LPS-induced RAW 264.7 cell inflammation model.CONCLUSION Based on the concept of"ingredient-target-pathway",this study evaluates the anti-inflammatory effect of Anchang formulation and its active ingredients,pre-dicts the potential mechanism of treatment for UC,and provides a theoretical basis and research ideas for the quality control of the for-mulation and its treatment for UC.
8.The research progress of ubiquitination and deubiquitination in castration-resistant prostate cancer
Engui YANG ; Chen GONG ; Zhiyong TAN ; Yinglong HUANG ; Senmao LI ; Haihao LI ; Haifeng WANG ; Mingxia DING
Chinese Journal of Urology 2025;46(4):312-315
The treatment of castration-resistant prostate cancer (CRPC) faces major challenges characterized by acquired resistance to androgen deprivation therapy (ADT) and consequent aggressive tumor progression. In this context, ubiquitination and deubiquitination modifications, as key protein post-translational modifications, play a crucial role in prostate tumourigenesis and progression. In recent years, the regulation of ubiquitination and deubiquitination in CRPC by the androgen receptor signalling pathway and the tumour microenvironment has received extensive attention, and these dynamic regulatory processes have become important molecular events driving CRPC progression by affecting the proliferation, metastasis, and immune escape ability of tumour cells. Therefore, in-depth analysis of the mechanisms of ubiquitination and deubiquitination in CRPC will help develop new therapeutic targets and provide more therapeutic options for patients.
9.The research progress of ubiquitination and deubiquitination in castration-resistant prostate cancer
Engui YANG ; Chen GONG ; Zhiyong TAN ; Yinglong HUANG ; Senmao LI ; Haihao LI ; Haifeng WANG ; Mingxia DING
Chinese Journal of Urology 2025;46(4):312-315
The treatment of castration-resistant prostate cancer (CRPC) faces major challenges characterized by acquired resistance to androgen deprivation therapy (ADT) and consequent aggressive tumor progression. In this context, ubiquitination and deubiquitination modifications, as key protein post-translational modifications, play a crucial role in prostate tumourigenesis and progression. In recent years, the regulation of ubiquitination and deubiquitination in CRPC by the androgen receptor signalling pathway and the tumour microenvironment has received extensive attention, and these dynamic regulatory processes have become important molecular events driving CRPC progression by affecting the proliferation, metastasis, and immune escape ability of tumour cells. Therefore, in-depth analysis of the mechanisms of ubiquitination and deubiquitination in CRPC will help develop new therapeutic targets and provide more therapeutic options for patients.
10.Advances in role of gut-liver axis in non-alcoholic fatty liver disease
Mingxia DING ; Yawen LUO ; Yihuai HE
Journal of Clinical Medicine in Practice 2025;29(7):143-148
The gut-liver axis is critical pathway of interaction between the intestine and the liver,involving gut microbiota,intestinal permeability and immune responses.Dysbiosis of the gut microbio-ta and increased intestinal permeability lead to the translocation of bacteria and their metabolites into the systemic circulation,thereby triggering hepatic inflammation and promoting the progression of non-alcoholic fatty liver disease(NAFLD).Research on the gut-liver axis contributes to the development of novel therapeutic approaches,including fecal microbiota transplantation,antibiotic therapy and nu-tritional intervention,providing new insights for the treatment of NAFLD.This article reviewed the composition and regulatory mechanism of entero-hepatic axis,its relationship with NAFLD,and the role of drug therapy and lifestyle intervention.

Result Analysis
Print
Save
E-mail